Literature DB >> 19421172

High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study.

D Bresters1, I C M van Gils, W J W Kollen, L M Ball, W Oostdijk, J G van der Bom, R M Egeler.   

Abstract

The aim of our study was to assess the cumulative incidence and severity ('burden') of late effects in a single-centre cohort of childhood haematopoietic stem cell transplantation (HSCT) survivors, at least 2 years after transplantation. The presence and severity of late effects in each survivor was documented according to the Common Terminology Criteria for Adverse Events (version 3.0). The burden of late effects was graded from mild to disabling/life-threatening. Risk factors for a high burden of late effects were assessed by univariate and multivariate logistic regression analyses. Among 162 survivors of HSCT seen in our late effects outpatient clinic, cumulative incidence of late effects was 93.2% after a median follow-up time of 7.2 years (range 2.0-21.0 years) after HSCT. The burden of late effects was mild, moderate, severe and disabling in 28, 41, 24 and 1% of survivors respectively. Risk factors for a severe or disabling burden of late effects were older age at HSCT (P for trend <0.001) and a conditioning regimen including irradiation OR 2.2, 95% CI 1.1-4.7, P=0.03). In conclusion, a high burden of late effects is found in childhood HSCT survivors after a median follow-up of only 7 years.

Entities:  

Mesh:

Year:  2009        PMID: 19421172     DOI: 10.1038/bmt.2009.92

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  26 in total

1.  Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.

Authors:  Nandita Khera; Barry Storer; Mary E D Flowers; Paul A Carpenter; Yoshihiro Inamoto; Brenda M Sandmaier; Paul J Martin; Stephanie J Lee
Journal:  J Clin Oncol       Date:  2011-12-05       Impact factor: 44.544

2.  Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institution.

Authors:  Francesco Felicetti; Rosaria Manicone; Andrea Corrias; Chiara Manieri; Eleonora Biasin; Ilaria Bini; Giuseppe Boccuzzi; Enrico Brignardello
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-16       Impact factor: 4.553

3.  Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood.

Authors:  D Bresters; D C M Wanders; M Louwerens; L M Ball; M Fiocco; R van Doorn
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

4.  NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions.

Authors:  K Scott Baker; Smita Bhatia; Nancy Bunin; Michael Nieder; Christopher C Dvorak; Lillian Sung; Jean E Sanders; Joanne Kurtzberg; Michael A Pulsipher
Journal:  Biol Blood Marrow Transplant       Date:  2011-06-30       Impact factor: 5.742

Review 5.  The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies.

Authors:  Andrew C Dietz; Christine N Duncan; Blanche P Alter; Dorine Bresters; Morton J Cowan; Luigi Notarangelo; Philip S Rosenberg; Shalini Shenoy; Roderick Skinner; Mark C Walters; John Wagner; K Scott Baker; Michael A Pulsipher
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-11       Impact factor: 5.742

6.  Safety and Feasibility of Rehabilitation Interventions in Children Undergoing Hematopoietic Stem Cell Transplant With Thrombocytopenia.

Authors:  Katarzyna Ibanez; Noel Espiritu; Regine L Souverain; Laura Stimler; Lauren Ward; Elyn R Riedel; Rachel Lehrman; Farid Boulad; Michael Dean Stubblefield
Journal:  Arch Phys Med Rehabil       Date:  2017-08-12       Impact factor: 3.966

Review 7.  Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.

Authors:  Andrew C Dietz; Sharon A Savage; Adrianna Vlachos; Parinda A Mehta; Dorine Bresters; Jakub Tolar; Carmem Bonfim; Jean Hugues Dalle; Josu de la Fuente; Roderick Skinner; Farid Boulad; Christine N Duncan; K Scott Baker; Michael A Pulsipher; Jeffrey M Lipton; John E Wagner; Blanche P Alter
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-19       Impact factor: 5.742

8.  Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort Study.

Authors:  Hesham M Eissa; Lu Lu; Malek Baassiri; Nickhill Bhakta; Matthew J Ehrhardt; Brandon M Triplett; Daniel M Green; Daniel A Mulrooney; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  Blood Adv       Date:  2017-11-07

Review 9.  Long-term Effects of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia.

Authors:  Anita Lawitschka; Christina Peters
Journal:  Curr Oncol Rep       Date:  2018-08-03       Impact factor: 5.075

10.  Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.

Authors:  D Bresters; A Lawitschka; C Cugno; U Pötschger; A Dalissier; G Michel; K Vettenranta; M Sundin; A Al-Seraihy; M Faraci; P Sedlacek; A B Versluys; A Jenkins; P Lutz; B Gibson; A Leiper; M A Diaz; P J Shaw; R Skinner; T A O'Brien; N Salooja; P Bader; C Peters
Journal:  Bone Marrow Transplant       Date:  2016-06-27       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.